OWA
EW icon

Opal Wealth Advisors’s Edwards Lifesciences EW Stock Holding History

Opal Wealth Advisors’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-714
Closed -$57.2K – 353
2026
Q1 		$57.2K Buy
+714
New +$58.9K 0.01% 378
2025
Q3 		– Sell
-874
Closed -$68.4K – 321
2025
Q2 		$68.4K Buy
874
+95
+12% +$7.08K 0.02% 326
2025
Q1 		$56.5K Buy
+779
New +$55.8K 0.02% 346
2024
Q3 		– Sell
-1,488
Closed -$137K – 517
2024
Q2 		$137K Buy
+1,488
New +$132K 0.04% 233

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Opal Wealth Advisors's EW Position: Q2 2026 in Review

Opal Wealth Advisors sold out of Edwards Lifesciences (EW) in Q2 2026, closing a stake of 714 shares — an estimated $57.2K sold.

Opal Wealth Advisors first reported a position in EW in Q2 2024 and held it in 4 quarters. The position peaked at $137K in Q2 2024. 1,325 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Opal Wealth Advisors reported no remaining Edwards Lifesciences position as of Q2 2026 after selling out during the quarter.
  • Opal Wealth Advisors sold 714 Edwards Lifesciences shares in Q2 2026, an estimated $57.2K.
  • Opal Wealth Advisors first reported a position in Edwards Lifesciences in Q2 2024 and held it in 4 quarters.
  • Opal Wealth Advisors's Edwards Lifesciences position peaked at $137K in Q2 2024.
  • 1,325 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Opal Wealth Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.